S. Gail Eckhardt, MD

Portrait of S. Gail Eckhardt, MD

S. Gail Eckhardt, MD

Associate Dean of Cancer Programs

Director, LIVESTRONG Cancer Institutes
Chair of Oncology
Professor of Internal Medicine

S. Gail Eckhardt, a visionary cancer leader, educator and research innovator, is the inaugural director of the LIVESTRONG Cancer Institutes of the Dell Medical School. She is overseeing the creation of a transdisciplinary cancer research program at UT Austin, one that will lead to new models of prevention, treatment, patient-centered cancer care; and new models of teaching and training future doctors.

Dr. Eckhardt began working at Dell Medical School in September but will take the reins of the institutes full time in January.

Dr. Eckhardt comes to the Dell Medical School from the University of Colorado Denver’s Anschutz Medical Campus, where she led the Division of Medical Oncology for eight years, holds the Stapp/Harlow Endowed Chair for Cancer Research, is associate director of translational research, and directs the Phase I Program at the NCI-designated University of Colorado Cancer Center.

She graduated from the University of Texas Medical Branch in Galveston and, before moving to Colorado, served as associate director of clinical research at the Cancer Therapy and Research Center, Institute for Drug Development, in San Antonio.

Dr. Eckhardt conducted her internship and residency in internal medicine at the University of Virginia Medical School. She completed a post-doctoral research fellowship in experimental and molecular medicine at Scripps Research Institute and a fellowship in Medical Oncology at the University of California, San Diego.

Dr. Eckhardt has served in many national leadership roles, including the American Society of Clinical Oncology (ASCO) Molecular Oncology Task Force, the ASCO Board of Directors, the FDA Oncology Drugs Advisory Committee and the National Cancer Institute (NCI) Cancer Centers Study Section. She is a member of the NCI Investigational Drug Steering Committee, the NCI Colorectal Cancer Task Force and serves on seven external advisory boards of NCI designated cancer centers.

A research innovator, Dr. Eckhardt is the principal investigator on studies involving early clinical trials and colorectal cancer research. She has conducted numerous phase I and II clinical trials and has published over 177 manuscripts.